Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 19, 2015
Amneal Pharmaceuticals has announced the launch of aripiprazole oral solution in 1 mg/mL strength.
read more
Wednesday, August 19, 2015
Boehringer Ingelheim has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for an update to the European label for Giotrif®.
read more
Wednesday, August 19, 2015
Merck is recalling 276,000 bottles of a chemotherapy drug because the child-proof caps on the pill bottles may be cracked.
read more
Wednesday, August 19, 2015
Amgen will pay $71 million to settle an investigation into illegal marketing of its drugs Aranesp and Enbrel, ending an investigation by 48 states and Washington DC.
read more
Cirrus Pharmaceuticals, a Kemwell company, has announced that Andrew Hamer has joined as VP R&D.
read more
Biologics, Inc. has been selected by AstraZeneca as a specialty pharmacy provider for IRESSA® (gefitinib). IRESSA® was approved by the FDA on July 13, 2015, for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC).
read more
Mylan lowered the bar for shareholder approval in its ongoing hostile bid for rival pharmaceutical company Perrigo.
read more
HiFiBiO SAS has announced that the company has achieved a milestone in its research collaboration with Pfizer triggering a milestone payment to HiFiBiO.
read more
Thursday, August 13, 2015
The medications produced at a GlaxoSmithKline pharmaceutical plant are safe despite the decision to close the factory after the discovery of the bacteria that causes potentially fatal Legionnaires' disease, the company said Wednesday.
read more
Wednesday, August 12, 2015
The Food and Drug Administration says Kardashian's social media posts violate federal drug-promotion rules.
read more
Wednesday, August 12, 2015
GE has reached an agreement to sell $8.5 billion of healthcare-related loans and its Healthcare Financial Services (HFS) U.S. lending business to Capital One for approximately $9 billion.
read more
Wednesday, August 12, 2015
Dr Nick Hutchinson from Parker domnick hunter, will be delivering a presentation at BioProduction 2015 about quality by design (QbD) and how it can be integrated into a bioprocess to ensure control over the post approval life cycle management plan.
read more
Wednesday, August 12, 2015
Asterand Bioscience has announced the acquisition of AdeptBio LLC, a Memphis-based biobank organization, which specializes in procurement of human tissue specimens.
read more
Wednesday, August 12, 2015
GlaxoSmithKline shut down a plant Tuesday that produces inhaled medications after discovering the bacteria that causes Legionnaire's disease, a potentially fatal form of pneumonia.
read more
iCardiac Technologies, a provider of cardiac safety assessment services to the pharmaceutical industry, has added respiratory and ePRO services to its suite of offerings through the acquisition of the clinical trials division of nSpire Health.
read more